Sign in

CIK 0001710072 · Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821725586
Phone
720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 144 Insider Sale of Securities
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 8-K Event Executive or director change
  5. 144 Insider Sale of Securities
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $21.12 ($2,112,450)
  9. 4 Open-market buy Director bought 10,700 shares at $18.64 ($199,403)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 144 Insider Sale of Securities
  13. 8-K Event Executive or director change · Regulation FD disclosure
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 4 Grant or award Director acquired 728 shares (grant or award)
  17. 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $14.60 ($1,459,760)
  18. 144 Insider Sale of Securities
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale General Counsel sold 2,098 shares at $13.39 ($28,097)

Page 4 of 22 · 423 filings